Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
16.14
-0.73 (-4.33%)
Feb 21, 2025, 4:00 PM EST - Market closed
Core Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 523.85 | 509.79 | 489.74 | 470.25 | 487.27 | Upgrade
|
| Revenue Growth (YoY) | 2.76% | 4.10% | 4.14% | -3.49% | -27.08% | Upgrade
|
| Cost of Revenue | 420.52 | 399.96 | 393.66 | 367.9 | 385.14 | Upgrade
|
| Gross Profit | 103.33 | 109.83 | 96.08 | 102.36 | 102.13 | Upgrade
|
| Selling, General & Admin | 38.59 | 38.89 | 37.57 | 43.87 | 32.53 | Upgrade
|
| Other Operating Expenses | -2.32 | -1.21 | -1.71 | -1.32 | -0.9 | Upgrade
|
| Operating Expenses | 51.23 | 53.47 | 53.03 | 61.06 | 52.5 | Upgrade
|
| Operating Income | 52.1 | 56.36 | 43.05 | 41.3 | 49.63 | Upgrade
|
| Interest Expense | -12.37 | -13.43 | -11.57 | -9.15 | -14.37 | Upgrade
|
| Earnings From Equity Investments | 0.24 | 0.39 | 0.29 | 0.06 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.2 | -0.18 | -0.23 | 0.23 | -1.16 | Upgrade
|
| EBT Excluding Unusual Items | 38.77 | 43.15 | 31.55 | 32.44 | 34.22 | Upgrade
|
| Merger & Restructuring Charges | -2.1 | -1.14 | -3.33 | - | -3.94 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -114 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.78 | 0.2 | 1.07 | 1.44 | 1.25 | Upgrade
|
| Asset Writedown | -0.7 | -1.15 | - | - | -8.2 | Upgrade
|
| Other Unusual Items | - | 0.15 | - | - | -0.5 | Upgrade
|
| Pretax Income | 46.19 | 41.21 | 29.95 | 36.11 | -91.18 | Upgrade
|
| Income Tax Expense | 14.03 | 4.19 | 10.3 | 15.89 | 5.9 | Upgrade
|
| Earnings From Continuing Operations | 32.15 | 37.03 | 19.66 | 20.22 | -97.07 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -0.42 | Upgrade
|
| Net Income to Company | 32.15 | 37.03 | 19.66 | 20.22 | -97.5 | Upgrade
|
| Minority Interest in Earnings | -0.75 | -0.35 | -0.21 | -0.49 | -0.14 | Upgrade
|
| Net Income | 31.4 | 36.68 | 19.45 | 19.73 | -97.64 | Upgrade
|
| Net Income to Common | 31.4 | 36.68 | 19.45 | 19.73 | -97.64 | Upgrade
|
| Net Income Growth | -14.38% | 88.53% | -1.39% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 47 | 47 | 46 | 46 | 44 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 48 | 47 | 47 | 44 | Upgrade
|
| Shares Change (YoY) | 0.34% | 1.52% | 0.26% | 4.98% | -0.38% | Upgrade
|
| EPS (Basic) | 0.67 | 0.79 | 0.42 | 0.43 | -2.20 | Upgrade
|
| EPS (Diluted) | 0.66 | 0.77 | 0.42 | 0.42 | -2.20 | Upgrade
|
| EPS Growth | -14.29% | 83.40% | -0.04% | - | - | Upgrade
|
| Free Cash Flow | 43.36 | 14.21 | 14.74 | 23.04 | 45.99 | Upgrade
|
| Free Cash Flow Per Share | 0.91 | 0.30 | 0.31 | 0.49 | 1.03 | Upgrade
|
| Dividend Per Share | 0.040 | 0.040 | 0.040 | 0.040 | 0.280 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | -85.71% | -87.27% | Upgrade
|
| Gross Margin | 19.72% | 21.54% | 19.62% | 21.77% | 20.96% | Upgrade
|
| Operating Margin | 9.95% | 11.06% | 8.79% | 8.78% | 10.18% | Upgrade
|
| Profit Margin | 5.99% | 7.19% | 3.97% | 4.19% | -20.04% | Upgrade
|
| Free Cash Flow Margin | 8.28% | 2.79% | 3.01% | 4.90% | 9.44% | Upgrade
|
| EBITDA | 67.05 | 72.15 | 60.22 | 59.81 | 70.49 | Upgrade
|
| EBITDA Margin | 12.80% | 14.15% | 12.30% | 12.72% | 14.47% | Upgrade
|
| D&A For EBITDA | 14.95 | 15.78 | 17.16 | 18.52 | 20.87 | Upgrade
|
| EBIT | 52.1 | 56.36 | 43.05 | 41.3 | 49.63 | Upgrade
|
| EBIT Margin | 9.95% | 11.06% | 8.79% | 8.78% | 10.18% | Upgrade
|
| Effective Tax Rate | 30.39% | 10.16% | 34.37% | 44.01% | - | Upgrade
|
| Revenue as Reported | 523.85 | 509.79 | 489.74 | 470.25 | 487.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.